About UsCHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 READ MORE
Press ReleaseCardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 READ MORE
About UsFirst treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 READ MORE
Press ReleaseVALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Dec 4, 2025 READ MORE
Press ReleaseVALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Dec 4, 2025 READ MORE
